ArticleBioinformatics advances2026
Classification of driver and passenger mutations in different cancer types using deep neural networks.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Cancer is driven by genetic changes, known as mutations, that lead to the uncontrolled division of cells. The functional significance of a vast number of these cancer somatic mutations is unknown, and it is one of the major challenges in cancer research. In this study, we performed an integrative analysis of 30 tumor types from PAN-cancer mutation data collected from the COSMIC database. We have analyzed a set of 61 364 missense mutations (57 535 drivers and 3829 passengers) from 682 cancer-causing genes and derived various important features from amino acid sequences, predicted AlphaFold structures, and amino acid contact networks. We observed that the motif-based preference, neighboring residue information, residue depth, and disorder regions around the site of mutation are important for the discrimination of drivers and passengers. Results: We further developed cancer-specific computational models to discriminate cancer-causing and passenger mutations using deep learning, and the integration of AlphaFold predicted structure information improved the pathogenicity prediction of mutations. Our method achieved an average classification accuracy of 84.06% with 10-fold cross-validation. Availability and implementation: The prediction server is available at https://web.iitm.ac.in/bioinfo2/PANDriver/index.html. We envisage that the AI-based prediction models would be an important tool to identify driver mutations and could extend the scope of precision medicine for cancer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.